ASHP

#ASHP26 registration is now open! Our Midyear Clinical Meeting & Exhibition is filled with possibilities - join your peers at the must-attend pharmacy event of the year to share knowledge and insight, discuss new ideas, and make connections that will help advance your career and practice: hubs.ly/Q04p_W_r0

From cell and gene therapies to pharmacogenomics, the next generation of therapeutics is already transforming patient care. Heidi Trinkman and Emilie Aschenbrenner join the ASHP Midyear Speaker Series to preview their #ASHP26 session, “Transforming Care Through Next-Generation Therapeutics: Theranostics, Cell and Gene Therapies, and Pharmacogenomics.” Get a preview of the conversation, then register for Midyear to learn more in Orlando: hubs.ly/Q04DXCr50

Although ketamine was initially used as a general anesthetic, it has since emerged as a valuable option for managing both acute and chronic pain. This CE podcast episode explores the role of intravenous ketamine across the perioperative setting, emergency medicine, and palliative care. Listen and download: hubs.ly/Q04DXgrq0

.@washingtonpost reports that the FDA “announced Monday that it is requiring manufacturers of GLP-1 medications to warn that they can increase the risk of” a condition that can lead to vision loss. This “warning applies to all GLP-1 medications.” washingtonpost.com/health/2026/11…

Our State Affiliate Presidential Officers Retreat is happening this week in Chicago! During this annual event, leaders from our state affiliates, ASHP Officers, and staff members gather to network and discuss key ASHP priorities. Thanks for your hard work!